BE810555A - Preparations stables de virus et leur procede de preparation - Google Patents

Preparations stables de virus et leur procede de preparation

Info

Publication number
BE810555A
BE810555A BE140507A BE140507A BE810555A BE 810555 A BE810555 A BE 810555A BE 140507 A BE140507 A BE 140507A BE 140507 A BE140507 A BE 140507A BE 810555 A BE810555 A BE 810555A
Authority
BE
Belgium
Prior art keywords
preparation process
virus preparations
stable virus
stable
preparations
Prior art date
Application number
BE140507A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE810555A publication Critical patent/BE810555A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16351—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16751—Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BE140507A 1973-02-09 1974-02-04 Preparations stables de virus et leur procede de preparation BE810555A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US330912A US3915794A (en) 1973-02-09 1973-02-09 Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them

Publications (1)

Publication Number Publication Date
BE810555A true BE810555A (fr) 1974-08-05

Family

ID=23291840

Family Applications (1)

Application Number Title Priority Date Filing Date
BE140507A BE810555A (fr) 1973-02-09 1974-02-04 Preparations stables de virus et leur procede de preparation

Country Status (18)

Country Link
US (1) US3915794A (fr)
JP (1) JPS5732043B2 (fr)
AT (1) AT331398B (fr)
BE (1) BE810555A (fr)
CA (1) CA1035700A (fr)
CH (1) CH592143A5 (fr)
DD (1) DD110306A5 (fr)
DE (1) DE2406167C2 (fr)
DK (1) DK134032B (fr)
ES (1) ES422961A1 (fr)
FR (1) FR2216997B1 (fr)
GB (1) GB1452344A (fr)
HU (1) HU169120B (fr)
IE (1) IE38825B1 (fr)
IL (1) IL44011A (fr)
NL (1) NL178013C (fr)
SE (1) SE427799B (fr)
ZA (1) ZA74163B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT71926B (en) * 1979-10-29 1982-03-31 Merck & Co Inc Process for preparing a liquid vaccine comprising a stabilizer
JPS57114527A (en) * 1979-10-29 1982-07-16 Merck & Co Inc Vaccine stabilizer
US4273762A (en) * 1979-12-03 1981-06-16 Merck & Co., Inc. Lyophilization process for live viral compositions
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
JPS6314729A (ja) * 1986-06-30 1988-01-21 スミスクライン・バイオロジカルス・ソシエテ・アノニム 生ワクチン用改良安定剤、その製造法およびそれを含有するワクチン
US4847078A (en) * 1987-01-14 1989-07-11 Arseco, Inc. Storage stable topical composition having moisture control agent
JPH01112853U (fr) * 1988-01-27 1989-07-28
US5045446A (en) * 1988-08-26 1991-09-03 Cryopharm Corporation Lyophilization of cells
IL90188A0 (en) * 1988-05-18 1989-12-15 Cryopharm Corp Process and medium for the lyophilization of erythrocytes
WO1991018504A1 (fr) * 1990-05-25 1991-12-12 Cryopharm Corporation Procede de lyophilisation de cellules, de matieres analogues a des cellules et de plaquettes dans un melange de polymeres amphipathiques biocompatibles
AU2088992A (en) * 1992-05-05 1993-11-11 Research Foundation For Microbial Diseases Of Osaka University, The Stabilized live vaccine
US5360736A (en) * 1992-06-04 1994-11-01 Merck & Co., Inc. Process for attenuated varicella zoster virus vaccine production
CA2097019C (fr) * 1992-06-04 2007-07-24 Philip J. Provost Procede de production d'un vaccin contenant les virus varicelle-zona attenues
WO1995010601A1 (fr) * 1993-10-12 1995-04-20 Chiron Viagene, Inc. Procedes de conservation de virus de recombinaison
EP0906110B1 (fr) * 1996-04-26 2004-12-22 Merck & Co., Inc. Formulations de vaccins a adn
ZA973642B (en) * 1996-04-26 1997-11-25 Merck & Co Inc DNA vaccine formulations.
US6051238A (en) * 1996-12-20 2000-04-18 Merck & Co., Inc. Stabilizers for lyophilized mumps vaccines
US6210683B1 (en) 1997-09-05 2001-04-03 Merck & Co., Inc. Stabilizers containing recombinant human serum albumin for live virus vaccines
US6926897B1 (en) * 1998-03-24 2005-08-09 Medigene Aktiengesellschaft Medicament for the avoidance or treatment of papillomavirus-specific tumour
DE19812940A1 (de) * 1998-03-24 1999-10-07 Medigene Ag Formulierung mit Papillomavirus-spezifischem Protein, seine Herstellung und Verwendung
GB9808922D0 (en) * 1998-04-24 1998-06-24 Cantab Pharmaceuticals Res Ltd Virus preparations
US6225289B1 (en) 1998-12-10 2001-05-01 Genvec, Inc. Methods and compositions for preserving adenoviral vectors
FR2814957B1 (fr) * 2000-10-06 2002-12-20 Aventis Pasteur Composition vaccinale et procede de stabilisation
US7013940B2 (en) * 2001-04-19 2006-03-21 Michelin Recherche Et Technique S.A. Device for attenuating cavity noise in a tire and wheel
UA78738C2 (en) * 2001-12-10 2007-04-25 Bavarian Nordic As Composition containing cowpox virus and method for its preparation
TWI398272B (zh) 2005-03-08 2013-06-11 Intervet Int Bv 化學定義的安定劑
EP1870649A1 (fr) * 2006-06-20 2007-12-26 Octapharma AG Lyophilisation visant à obtenir une humidité résiduelle déterminée par énergie de désorption aux niveaux limités
HUE035774T2 (en) 2011-08-12 2018-05-28 Merial Inc Biological substances, in particular vaccines, preserved by vacuum
TWI690322B (zh) * 2012-10-02 2020-04-11 法商傳斯堅公司 含病毒的調配物及其使用
CA2948845C (fr) 2014-05-14 2022-05-31 Merial, Inc. Procedes de lyophilisation et de rehydratation de produits biologiques
US10517943B2 (en) * 2014-12-01 2019-12-31 Transgene S.A. Stable liquid vaccinia virus formulations
CN105999287A (zh) * 2016-07-01 2016-10-12 广东圣戈生物科技有限公司 一种疫苗稀释液及其制备方法
BR112019006900A2 (pt) 2016-10-05 2019-07-02 Zoetis Services Llc métodos de liofilização que proporcionam protozoários desidratados estáveis para o uso como potentes vacinas vivas
CN111065732A (zh) 2017-09-11 2020-04-24 Imba-莫利库尔生物技术研究所 肿瘤类器官模型

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1292803A (en) * 1968-11-18 1972-10-11 Nat Res Dev Improvements relating to the production of antigens
US3642574A (en) * 1970-04-29 1972-02-15 Us Agriculture Method for producing vaccine for immunization of poultry against marek{3 s disease
US3783098A (en) * 1971-08-10 1974-01-01 Cornell Res Foundation Inc Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same

Also Published As

Publication number Publication date
US3915794A (en) 1975-10-28
AU6486574A (en) 1975-07-24
HU169120B (fr) 1976-09-28
IE38825L (en) 1974-08-09
DE2406167C2 (de) 1984-12-20
CA1035700A (fr) 1978-08-01
IE38825B1 (en) 1978-06-07
ZA74163B (en) 1974-11-27
FR2216997A1 (fr) 1974-09-06
ATA98274A (de) 1975-11-15
DD110306A5 (fr) 1974-12-12
CH592143A5 (fr) 1977-10-14
JPS49109518A (fr) 1974-10-18
FR2216997B1 (fr) 1978-01-06
IL44011A (en) 1977-04-29
AT331398B (de) 1976-08-25
NL178013C (nl) 1986-01-02
DE2406167A1 (de) 1974-08-15
NL178013B (nl) 1985-08-01
NL7401786A (fr) 1974-08-13
IL44011A0 (en) 1974-05-16
ES422961A1 (es) 1976-06-01
GB1452344A (en) 1976-10-13
JPS5732043B2 (fr) 1982-07-08
DK134032C (fr) 1977-02-07
SE427799B (sv) 1983-05-09
DK134032B (da) 1976-08-30

Similar Documents

Publication Publication Date Title
BE810555A (fr) Preparations stables de virus et leur procede de preparation
BE810310A (fr) 4-phenylpiperidines et leur preparation
FR2288089A1 (fr) Nouveaux herbicides et procede de leur preparation
BE823400A (fr) Derives de 2-acyl-4-oxo-pyrazino-isoquinoleine et leur procede de preparation
FR2301561A1 (fr) Emulsions aqueuses stables et procede de leur preparation
BE822616A (fr) Derives de 7alpha-methoxycephalosporine leur procede de preparation et leur application therapeutique
BE823027A (fr) Derives d'isoquinoleine et leur procede de preparation
BE820163A (fr) Triazolopyridazines et leur preparation
BE823973A (fr) Beta-aminoethylsilanes et leur procede de preparation
BE818055A (fr) Derives de dibenzoxepine et leur procede de preparation
FR2280386A1 (fr) 7-methoxy-6-thia-tetracyclines et leur procede de preparation
BE820385A (fr) D-homo-steroides et leur procede de preparation
BE822496A (fr) Derives d'acide hydratropique et leur procede de preparation
BE819321A (fr) Nouveaux 2,3-dihydrobenzofuranyl-7-n-methyl-carbamates n-sulfenyles, leur procede de preparation et leur application
BE836526A (fr) Substances actives antimicrobiennes et leur procede de preparation
BE830814A (fr) N-alkyl-iminoalanes oligomeres et leur procede de preparation
BE820653A (fr) Agents edulcorants et leur procede de preparation
BE814117A (fr) Aza-2 cycloalkylmethylcetones et leur procede de preparation
BE814118A (fr) Phenylmethanols et phenylcetones aza-2 cycloalkylmethyl-substitues et leur procede de preparation
BE809984A (fr) Colorants et leur procede de preparation
BE818923A (fr) N-(2,4-dihalogeno-s-triazin-6-yl)-urees et leur procede de preparation
BE816947A (fr) Acides oligocarboxy-alkane-phosphoniques et leur preparation
BE811259A (fr) Derives de phenothiazine 3-substitues et leur preparation
BE810427A (fr) Derives de xanthene et leur procede de preparation
BE823873A (fr) Derives de benzopyranne et leur procede de preparation